Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.
Beyond the Ordinary Beyond the Obvious
Beyond the Ordinary Beyond the Obvious
Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.
